Apixaban conferred lower bleeding risk during a 3-month period compared with rivaroxaban in patients with acute venous thromboembolism, researchers reported.Despite higher medication adherence to ...

The risk for clinically relevant bleeding is significantly lower with apixaban than with rivaroxaban among patients with acute venous thromboembolism, according to a study published in the March 12/19 ...

Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...

Thus, despite these findings, the mechanisms associated with hemostasis disruption following long-distance flights remain poorly understood. With billions of air travelers each year, it is essential ...

D-dimer testing is useful for excluding venous thromboembolism (VTE), where a low D-dimer level helps exclude deep vein thrombosis (DVT) and pulmonary embolism (PE).[1][1] However, elevated levels are ...

Elizabeth Simms was 27 and pregnant when she was struck with a life-threatening pulmonary embolism. Her fourth pregnancy had ...

Patients undergoing surgery for degenerative lumbar spine disease did worse when they received anticoagulants as part of the ...

Global Heparin Market OverviewThe Global Heparin Market is projected to grow steadily at a CAGR of approximately 5% by 2026.

The Johns Hopkins Armstrong Institute for Patient Safety and Quality leads national VTE prevention efforts through its Venous Thromboembolism (VTE) Collaborative, which aims to advance evidence-based ...

Factors Associated with Venous Thromboembolic Disease in a Group of Sub-Saharan Afrcan Population Followed-Up for Cervical ...

Recent developments of interest in cardiovascular medicine ...

About the National Blood Clot Alliance: The National Blood Clot Alliance is the nation’s leading nonprofit voluntary health organization dedicated to advancing the prevention, early diagnosis, and ...